You have 9 free searches left this month | for more free features.

Condition

NSCLC (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Bristol-Myers Squibb (1)

Collaborator

Intervention

bms-986315 (1)

carboplatin (1)

cisplatin (1)

nivolumab (1)

paclitaxel (1)

pemetrexed (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

bms-986315

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting

NSCLC

BMS-986315
+5 more

Boise, Idaho
+12 more

Oct 17, 2023